Nectar Lifesciences shares drop 15% after announcing sale of core business for ₹1,270 crore

The proceeds from the sale will be used to repay existing debt, invest in new and emerging business areas, reward shareholders (subject to applicable approvals) and fund future corporate and growth initiatives.

Leave a Reply

Your email address will not be published. Required fields are marked *